These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30590590)

  • 61. Meta-analysis of the placebo response in ulcerative colitis.
    Garud S; Brown A; Cheifetz A; Levitan EB; Kelly CP
    Dig Dis Sci; 2008 Apr; 53(4):875-91. PubMed ID: 17934839
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Methotrexate for maintenance of remission in ulcerative colitis.
    El-Matary W; Vandermeer B; Griffiths AM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007560. PubMed ID: 19588435
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.
    Mosli MH; MacDonald JK; Bickston SJ; Behm BW; Tsoulis DJ; Cheng J; Khanna R; Feagan BG
    Inflamm Bowel Dis; 2015 May; 21(5):1151-9. PubMed ID: 25844963
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Drug therapies for ulcerative proctitis: systematic review and meta-analysis.
    Lie MR; Kanis SL; Hansen BE; van der Woude CJ
    Inflamm Bowel Dis; 2014 Nov; 20(11):2157-78. PubMed ID: 25072502
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Factors associated with mucosal healing in patients with ulcerative colitis in clinical remission.
    Shi HY; Chan FK; Tsang SW; Hui YT; Sze SF; Ching JY; Chung T; Iu CY; Lo FH; Shan EH; Li MK; Wu JC; Sung JJ; Ng SC
    Inflamm Bowel Dis; 2015 Apr; 21(4):840-6. PubMed ID: 25738375
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis.
    Narula N; Alshahrani AA; Yuan Y; Reinisch W; Colombel JF
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):411-418.e3. PubMed ID: 29913273
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis.
    Stawowczyk E; Kawalec P
    Pharmacoeconomics; 2018 Apr; 36(4):419-434. PubMed ID: 29260508
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Park S; Abdi T; Gentry M; Laine L
    Am J Gastroenterol; 2016 Dec; 111(12):1692-1701. PubMed ID: 27725645
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis.
    Feagan BG; Sandborn WJ; D'Haens G; Pola S; McDonald JWD; Rutgeerts P; Munkholm P; Mittmann U; King D; Wong CJ; Zou G; Donner A; Shackelton LM; Gilgen D; Nelson S; Vandervoort MK; Fahmy M; Loftus EV; Panaccione R; Travis SP; Van Assche GA; Vermeire S; Levesque BG
    Gastroenterology; 2013 Jul; 145(1):149-157.e2. PubMed ID: 23528626
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A longitudinal model for the Mayo Clinical Score and its sub-components in patients with ulcerative colitis.
    Kawakatsu S; Zhu R; Zhang W; Tang MT; Lu T; Quartino AL; Kågedal M
    J Pharmacokinet Pharmacodyn; 2022 Apr; 49(2):179-190. PubMed ID: 34657238
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta-analysis.
    Magro F; Alves C; Santiago M; Ministro P; Lago P; Correia L; Gonçalves R; Carvalho D; Portela F; Dias CC; Dignass A; Danese S; Peyrin-Biroulet L; Estevinho MM; Moreira P;
    United European Gastroenterol J; 2022 Feb; 10(1):54-72. PubMed ID: 34907660
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Curcumin use in ulcerative colitis: is it ready for prime time? A systematic review and meta-analysis of clinical trials.
    Chandan S; Mohan BP; Chandan OC; Ahmad R; Challa A; Tummala H; Singh S; Dhawan P; Ponnada S; Singh AB; Adler DG
    Ann Gastroenterol; 2020; 33(1):53-58. PubMed ID: 31892798
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Time spent per day in strenuous activity and total physical activity are inversely associated with mucosal healing but not with clinical remission in patients with ulcerative colitis.
    Watanabe J; Furukawa S; Yagi S; Shiraishi K; Hanayama M; Tange K; Hashimoto Y; Kitahata S; Mori K; Ninomiya T; Suzuki S; Shibata N; Murakami H; Ohashi K; Hasebe A; Tomida H; Yamamoto Y; Takeshita E; Ikeda Y; Hiasa Y
    Ann Gastroenterol; 2021; 34(6):796-801. PubMed ID: 34815645
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials.
    Hibi T; Naganuma M; Oda E; Yamada Y; Chujoh Y; Yoshihara R; Watanabe M
    Intest Res; 2020 Jan; 18(1):56-68. PubMed ID: 31813214
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort.
    Yokoyama Y; Ohta Y; Ogasawara S; Kato J; Arai R; Koseki H; Saito M; Kaneko T; Tokunaga M; Oura H; Oike T; Imai Y; Kanayama K; Akizue N; Kumagai J; Taida T; Okimoto K; Saito K; Ooka Y; Matsumura T; Nakagawa T; Arai M; Katsuno T; Fukuda Y; Kitsukawa Y; Kato N
    Sci Rep; 2022 Dec; 12(1):21060. PubMed ID: 36473879
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The 2 + 1 paradigm: an efficient algorithm for central reading of Mayo endoscopic subscores in global multicenter phase 3 ulcerative colitis clinical trials.
    Ahmad HA; Gottlieb K; Hussain F
    Gastroenterol Rep (Oxf); 2016 Feb; 4(1):35-8. PubMed ID: 26361984
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stringent criteria for withdrawal of biologics in ulcerative colitis.
    Tan M; Ng V; Lim CT; Leow WQ; Chan W
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):687-688. PubMed ID: 34391517
    [No Abstract]   [Full Text] [Related]  

  • 78. High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease.
    Barnes EL; Long MD; Kappelman MD; Martin CF; Sandler RS
    Inflamm Bowel Dis; 2019 Jun; 25(7):1248-1254. PubMed ID: 30590700
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interactions Between Autophagy and the Unfolded Protein Response: Implications for Inflammatory Bowel Disease.
    Hooper KM; Barlow PG; Henderson P; Stevens C
    Inflamm Bowel Dis; 2019 Mar; 25(4):661-671. PubMed ID: 30590697
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease.
    Arihiro S; Nakashima A; Matsuoka M; Suto S; Uchiyama K; Kato T; Mitobe J; Komoike N; Itagaki M; Miyakawa Y; Koido S; Hokari A; Saruta M; Tajiri H; Matsuura T; Urashima M
    Inflamm Bowel Dis; 2019 May; 25(6):1088-1095. PubMed ID: 30601999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.